Ask Warren

PharmGen Science

004720 · KOSPI · ₩004720 · 팜젠사이언스

₩2,765▲ ₩15 (0.55%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩48B₩43B₩43B₩42B₩46B₩43B₩44B₩42B
Cost of sales₩16B₩15B₩16B₩14B₩15B₩16B₩16B₩15B
Gross profit₩32B₩28B₩27B₩27B₩31B₩27B₩28B₩27B
Operating income₩1.8B₩1.8B−₩753M₩1.4B₩3.3B₩2B₩1.9B₩3.1B
Net income−₩14B−₩988M−₩118B−₩2.3B₩2.4B₩740M₩3.3B₩1.3B
Net income to shareholders−₩14B−₩988M−₩118B−₩2.3B₩2.4B₩740M₩3.3B₩1.3B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩184B₩199B₩195B₩331B₩331B₩182B₩203B₩198B
Current assets₩92B₩92B₩96B₩94B₩94B₩90B₩111B₩103B
Cash and equivalents₩20B₩18B₩22B₩14B₩13B₩13B₩38B₩33B
Total liabilities₩44B₩49B₩49B₩84B₩85B₩61B₩83B₩80B
Current liabilities₩28B₩32B₩34B₩42B₩44B₩43B₩65B₩64B
Borrowings₩0₩5.5B₩5.5B₩18B₩18B₩19B₩38B₩38B
Total equity₩140B₩150B₩146B₩248B₩245B₩121B₩120B₩118B
Shareholders' equity₩140B₩150B₩146B₩248B₩245B₩121B₩120B₩118B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩5.1B₩1.6B₩8.7B₩1.9B−₩1.4B−₩3.9B₩3.4B₩104M
Capital spending₩159M₩943M₩485M₩440M₩413M₩126M₩208M₩52M
Free cash flow₩4.9B₩684M₩8.2B₩1.5B−₩1.8B−₩4B₩3.2B₩52M

Consolidated where available. Amounts in won.

Also known as: PharmGen Science / 팜젠사이언스 / 004720 / KRX:004720

Source: KRX statistical information